38
|
96
|
4driB |
Co-crystal structure of the ppiase domain of fkbp51, rapamycin and the frb fragment of mtor |
81
|
269
|
4enyA |
Crystal structure of pim-1 kinase in complex with (2e,5z)-2-(2-chlorophenylimino)-5-(4-hydroxy-3-methoxybenzylidene)thiazolidin-4-one |
44
|
200
|
4ebyA |
Crystal structure of the ectodomain of a receptor like kinase |
89
|
360
|
4e7wA |
Structure of gsk3 from ustilago maydis |
100
|
335
|
4eklA |
Akt1 with gdc0068 |
34
|
109
|
4eeuA |
Crystal structure of philov2.1 |
33
|
110
|
4eesA |
Crystal structure of ilov |
23
|
100
|
4eajA |
Co-crystal of ampk core with amp soaked with atp |
92
|
334
|
4ekkA |
Akt1 with amp-pnp |
21
|
99
|
4ealA |
Co-crystal of ampk core with atp soaked with amp |
83
|
273
|
4dtkA |
Novel and selective pan-pim kinase inhibitor |
78
|
269
|
4enxA |
Crystal structure of pim-1 kinase in complex with inhibitor (2e,5z)-2-(2-chlorophenylimino)-5-(4-hydroxy-3-nitrobenzylidene)thiazolidin-4-one |
23
|
89
|
4efoA |
Crystal structure of the ubiquitin-like domain of human tbk1 |
43
|
200
|
4ebzA |
Crystal structure of the ectodomain of a receptor like kinase |
0
|
10
|
4ekkC |
Akt1 with amp-pnp |
73
|
276
|
4ehgA |
B-raf kinase domain in complex with an aminopyridimine-based inhibitor |
33
|
110
|
4eepA |
Crystal structure of lov2 domain of arabidopsis thaliana phototropin 2 |
21
|
99
|
4eakA |
Co-crystal structure of an ampk core with atp |
69
|
274
|
4e4xA |
Crystal structure of b-raf kinase domain in complex with a dihydropyrido[2,3-d]pyrimidinone-based inhibitor |
72
|
276
|
4eheA |
B-raf kinase domain in complex with an aminothienopyrimidine-based inhibitor |
34
|
106
|
4eerA |
Crystal structure of lov2 domain of arabidopsis thaliana phototropin 2 c426a mutant |
130
|
506
|
4dugA |
Crystal structure of circadian clock protein kaic e318a mutant |
95
|
297
|
4eqcA |
Crystal structure of pak1 kinase domain in complex with frax597 inhibitor |
76
|
276
|
4e26A |
Braf in complex with an organic inhibitor 7898734 |
40
|
96
|
4drjB |
O-crystal structure of the ppiase domain of fkbp52, rapamycin and the frb fragment of mtor |
78
|
294
|
4equA |
Human stk-10 (lok) kinase domain in dfg-out conformation with inhibitor dsa-7 |
88
|
298
|
4el9A |
Structure of n-terminal kinase domain of rsk2 with afzelin |
89
|
299
|
4d9tA |
Rsk2 c-terminal kinase domain with inhibitor (e)-methyl 3-(4-amino-7-(3-hydroxypropyl)-5-p-tolyl-7h-pyrrolo[2,3-d]pyrimidin-6-yl)-2-cyanoacrylate |
103
|
333
|
4d2wA |
Structure of melk in complex with inhibitors |
93
|
302
|
4czuA |
Crystal structure of the kinase domain of cipk23 t190d mutant |
103
|
330
|
4cqgA |
The crystal structure of mpk38 in complex with otssp167, an orally- administrative melk selective inhibitor |
101
|
334
|
4dglC |
Crystal structure of the ck2 tetrameric holoenzyme |
75
|
262
|
4dhfA |
Structure of aurora a mutant bound to biogenidec cpd 15 |
98
|
334
|
4d2vA |
Structure of melk in complex with inhibitors |
78
|
284
|
4ct1A |
Human pdk1-pkczeta kinase chimera in complex with allosteric compound ps315 bound to the pif-pocket |
110
|
326
|
4dgnA |
Crystal structure of maize ck2 in complex with the inhibitor luteolin |
76
|
264
|
4debA |
Aurora a in complex with rk2-17-01 |
90
|
353
|
4ditA |
Crystal structure of gsk3beta in complex with a imidazopyridine inhibitor |
94
|
333
|
4d2tA |
Structure of melk in complex with inhibitors |
74
|
274
|
4dbnA |
Crystal structure of the kinase domain of human b-raf with a [1,3]thiazolo[5,4-b]pyridine derivative |
95
|
333
|
4d2pA |
Structure of melk in complex with inhibitors |
89
|
296
|
4cztA |
Crystal structure of the kinase domain of cipk23 |
86
|
271
|
4deeA |
Aurora a in complex with adp |
76
|
265
|
4dedA |
Aurora a in complex with yl1-038-21 |
96
|
294
|
4dawA |
Crystal structure of pak1 kinase domain with the ruthenium phthalimide complex |
63
|
282
|
4d28A |
Crystal structure of the kinase domain of cipk24/sos2 |
75
|
272
|
4cqeA |
B-raf kinase v600e mutant in complex with a diarylthiazole b-raf inhibitor |
82
|
266
|
4deaA |
Aurora a in complex with yl1-038-18 |
92
|
307
|
4d9uA |
Rsk2 c-terminal kinase domain, (e)-tert-butyl 3-(4-amino-7-(3-hydroxypropyl)-5-p-tolyl-7h-pyrrolo[2,3-d]pyrimidin-6-yl)-2-cyanoacrylate |
78
|
284
|
4ct2A |
Human pdk1-pkczeta kinase chimera |